Axon Enterprise, Inc $AXON Shares Purchased by USS Investment Management Ltd

USS Investment Management Ltd boosted its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 10.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 84,022 shares of the biotechnology company’s stock after purchasing an additional 7,900 shares during the quarter. USS Investment Management Ltd owned about 0.10% of Axon Enterprise worth $35,507,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. M & L Capital Management Ltd bought a new position in shares of Axon Enterprise during the third quarter worth $30,000. Morse Asset Management Inc acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $30,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at $31,000. Wealth Enhancement Trust Services Inc. bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at $33,000. Finally, Putney Financial Group LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at $36,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This trade represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 27,792 shares of company stock valued at $15,214,581 in the last quarter. 4.20% of the stock is currently owned by insiders.

Key Axon Enterprise News

Investors following AXON have been watching these news items:

Axon Enterprise Stock Performance

AXON opened at $306.98 on Friday. Axon Enterprise, Inc has a 12-month low of $291.11 and a 12-month high of $665.07. The stock has a market cap of $25.00 billion, a price-to-earnings ratio of 98.39, a PEG ratio of 7.28 and a beta of 1.48. The business has a 50 day moving average of $402.24 and a 200-day moving average of $463.73. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its earnings results on Friday, November 6th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). The business had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business’s revenue was up 27.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.17 earnings per share. On average, equities research analysts expect that Axon Enterprise, Inc will post 1.65 earnings per share for the current year.

Wall Street Analyst Weigh In

AXON has been the topic of several research analyst reports. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a research note on Monday, November 2nd. TD Cowen decreased their price target on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating for the company in a research note on Monday, October 26th. Piper Sandler reaffirmed an “overweight” rating and issued a $540.00 target price (down from $561.00) on shares of Axon Enterprise in a research report on Friday, November 6th. Finally, The Goldman Sachs Group dropped their price target on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating on the stock in a research report on Monday, September 21st. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $612.18.

Read Our Latest Stock Analysis on AXON

Axon Enterprise Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.